Skip to content

Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial

EMERALD: Can a Virtual Eye Movement Desensitisation and Reprocessing Intervention Improve Psychological Outcome Following Covid-19 Related Critical Illness: A Feasibility Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04455360
Acronym
Cov-EMERALD
Enrollment
26
Registered
2020-07-02
Start date
2020-10-01
Completion date
2021-09-20
Last updated
2021-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, COVID, Critical Care, Depression, Intensive Care Psychiatric Disorder, Post Traumatic Stress Disorder

Keywords

EMDR, Eye movement desensitisation and reprocessing

Brief summary

Primary objective is to evaluate the feasibility of delivering an online early Eye Movement Desensitisation Reprocessing (EMDR) Recent Traumatic Events Protocol (R-TEP) to patients who have survived Covid-19 related critical illness, within the context of a randomised controlled trial (RCT). This will inform the design of a future RCT investigating the effectiveness of EMDR R-TEP in reducing psychological symptoms, for adult survivors of intensive care.

Detailed description

A significant number of patients worldwide, have been admitted to intensive care suffering from Covid-19 related organ failure. Patients who survive a period of critical illness have a disproportionately high chance of suffering from significant and persistant poor psychological outcomes. Eye-Movement Desensitisation and Reprocessing (EMDR) has reduced incidence of psychological morbidity in war veterans and victims of man-made and natural disasters. Small studies have also shown it to be effective in healthcare settings, within the Emergency department, following cancer diagnosis and implantation of cardioverter defibrillators. EMDR is validated by UK National Institute of Clinical Excellence guidance for use in treating adult onset PTSD. Because of ongoing social distancing guidance our study programme aims to investigate whether it is feasible to treat patients with an early online Eye Movement Desensitisation Reprocessing (EMDR) intervention, delivered soon after hospital discharge and whether this intervention will improve psychological outcome for survivors of critical illness.

Interventions

OTHEREye Movement Desensitisation and Reprocessing Recent traumatic Event Protocol

EMDR is a form of psychotherapy treatment whereby the client verbally relates a narrative of a traumatic episode or emotionally disturbing material in brief sequential doses while simultaneously focusing on an external stimulus. The EMDR Recent-Traumatic Events protocol (R-TEP) aims to enable an individual to process memories of the event in order to reduce psychological morbidity. EMDR R-TEP should be delivered within 3-months of the onset of a traumatic event.

Sponsors

Dorset HealthCare University NHS Foundation Trust
CollaboratorOTHER
University Hospital Southampton NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

Patient reported outcomes at 6-months post-hospital discharge

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute admission to Critical Care who have required mechanical ventilation for at least 24 hours * PCR confirmed Covid-19 positive * \>18 years of age * Capacity to provide informed consent

Exclusion criteria

* Acute brain injury * Cognitive impairment * Pre-existing psychotic diagnosis * Not expected to survive post-hospital discharge * Refusal to grant consent

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of recruitment, intervention adherence, incidence of treatment related adverse events and trial completion to final assessment timepoints12 monthsFeasibility will be determined by the following measures: 1. Able to recruit \>30% of eligible patients approached 2. Complete early EMDR intervention programme in 75% or more of trial participants randomised to intervention. 3. Protocol adherence 4. Assignment of causality of serious events will be assessed by the chief investigator. Events attributable to trial procedures will be reviewed by trial management board, study sponsor and the research ethics committee, in order to determine ongoing feasibility. 5. Outcome measures completed in 75% or more of trial participants

Secondary

MeasureTime frameDescription
Anxiety and depression6 monthsHospital Anxiety and Depression Scale (HADS) is a 14-item, self-reported measure with 7-items relating to symptoms of anxiety and 7-items relating to depression
Cognitive function6 months post-hospital dischargeMontreal Cognitive Assessment (MoCA) is a validated tool, used to detect cogntive impairment
Health Related Quality of Life6 months post-hospital dischargeEQ5D -5L comprises five quality-of-life dimensions; mobility, self-care, usual activities, pain/discomfort andanxiety/depression.
Post-Traumatic stress disorder6 months post-hospital dischargeThe PTSD Checklist-Civilian Version (PCL-C) is a validated, standardised self-reporting questionnaire for PTSD comprising of 17 items that correspond to key PTSD symptoms
Physical activity6 months post-hospital dischargeWrist worn physical activity monitoring
Nutritional status6 months post-hospital dischargePatient generated subjective global assessment
Health and disability6 months post-hospital dischargeWHODAS 2.0 is a generic assessment tool that produces standarised disability levels and profiles

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026